NC
LLY icon

NBW Capital’s Eli Lilly LLY Stock Holding History

NBW Capital’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$362K Sell
464
-155
-25% -$120K 0.08% 78
2025
Q1 		$511K Sell
619
-125
-17% -$104K 0.11% 77
2024
Q4 		$575K Sell
744
-17
-2% -$14.1K 0.11% 76
2024
Q3 		$675K Sell
761
-21
-3% -$18.9K 0.13% 73
2024
Q2 		$708K Sell
782
-94
-11% -$75.2K 0.14% 75
2024
Q1 		$681K Buy
876
+103
+13% +$73.3K 0.14% 71
2023
Q4 		$450K Sell
773
-46
-6% -$26.9K 0.1% 73
2023
Q3 		$440K Sell
819
-166
-17% -$85.5K 0.11% 73
2023
Q2 		$462K Sell
985
-7
-0.7% -$2.94K 0.11% 75
2023
Q1 		$341K Sell
992
-400
-29% -$135K 0.08% 80
2022
Q4 		$509K Buy
1,392
+3
+0.2% +$1.06K 0.13% 74
2022
Q3 		$449K Buy
1,389
+303
+28% +$96K 0.12% 76
2022
Q2 		$352K Buy
+1,086
New +$326K 0.1% 80

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

NBW Capital's LLY Position: Q2 2025 in Review

NBW Capital reduced its Eli Lilly (LLY) stake by 25% in Q2 2025, selling an estimated $120K and leaving 464 shares worth $362K. The position accounts for 0.08% of the portfolio, ranked #78.

NBW Capital first reported a position in LLY in Q2 2022 and has held it in 13 quarters since. The position peaked at $708K in Q2 2024. 3,907 funds tracked by Wall St. Rank hold LLY as of Q2 2025.

  • NBW Capital held 464 shares of Eli Lilly worth $362K as of Q2 2025.
  • NBW Capital sold 155 Eli Lilly shares in Q2 2025, an estimated $120K.
  • Eli Lilly made up 0.08% of NBW Capital's portfolio in Q2 2025, its #78 holding.
  • NBW Capital first reported a position in Eli Lilly in Q2 2022 and has held it in 13 quarters since.
  • NBW Capital's Eli Lilly position peaked at $708K in Q2 2024.
  • 3,907 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2025.

Based on NBW Capital's 13F filing for Q2 2025, filed 13 Aug 2025.